Literature DB >> 8631593

Translational regulation of vascular permeability factor by eukaryotic initiation factor 4E: implications for tumor angiogenesis.

C G Kevil1, A De Benedetti, D K Payne, L L Coe, F S Laroux, J S Alexander.   

Abstract

Studies aimed at elucidating the function of the protein synthesis factor eukaryotic initiation factor 4E (elF-4E) have demonstrated that overexpression of this protein results in marked cell phenotypic and proliferative changes, including neoplastic transformation of cells. These data suggest that elF-4E may somehow participate in the development and progression of tumors in vivo. In order to determine how elF-4E exerts its transforming effects, we examined vascular permeability factor (VPF) levels in cells transfected with an elF-4E vector. Cells overexpressing elF-4E showed an increase in intracellular, and an average 130-fold increase in secreted VPF protein levels (CHO 0.13+/-0.12 ng/ml; CHO-4E 20.5+/-12.5 ng/ml) over control cells. HUVEC growth induction revealed these VPF levels to be biologically active. Northern analysis revealed no difference in VPF transcript between the 2 cell lines. Polysome analysis showed that the VPF message in elF-4E-transfected cells was associated with the heavy polysomal regions, whereas the VPF message was associated with light polysomes in control cells. These data strongly suggest that enhanced VPF expression is achieved through translational regulation rather than transcriptional regulation in cells overexpressing elF-4E. This indicates that elF-4E-induced VPF expression may be an important factor in some forms of tumor angiogenesis and development.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8631593     DOI: 10.1002/(SICI)1097-0215(19960315)65:6<785::AID-IJC14>3.0.CO;2-3

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  53 in total

1.  The 5' RNA terminus of spleen necrosis virus stimulates translation of nonviral mRNA.

Authors:  T M Roberts; K Boris-Lawrie
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

2.  High eIF4E, VEGF, and microvessel density in stage I to III breast cancer.

Authors:  Kerry Byrnes; Stephen White; Quyen Chu; Carol Meschonat; Herbert Yu; Lester W Johnson; Arrigo Debenedetti; Fleurette Abreo; Richard H Turnage; John C McDonald; Benjamin D Li
Journal:  Ann Surg       Date:  2006-05       Impact factor: 12.969

3.  Differential angiogenic regulation of experimental colitis.

Authors:  John H Chidlow; Will Langston; James J M Greer; Dmitry Ostanin; Maisoun Abdelbaqi; Jeffery Houghton; Annamalai Senthilkumar; Deepti Shukla; Andrew P Mazar; Matthew B Grisham; Christopher G Kevil
Journal:  Am J Pathol       Date:  2006-12       Impact factor: 4.307

4.  Murine rVEGF164b, an inhibitory VEGF reduces VEGF-A-dependent endothelial proliferation and barrier dysfunction.

Authors:  Walter Cromer; Merilyn H Jennings; Yoshinubo Odaka; J Michael Mathis; J Steven Alexander
Journal:  Microcirculation       Date:  2010-10       Impact factor: 2.628

5.  Translation of vascular endothelial growth factor mRNA by internal ribosome entry: implications for translation under hypoxia.

Authors:  I Stein; A Itin; P Einat; R Skaliter; Z Grossman; E Keshet
Journal:  Mol Cell Biol       Date:  1998-06       Impact factor: 4.272

Review 6.  Establishing a link between oncogenes and tumor angiogenesis.

Authors:  R S Kerbel; A Viloria-Petit; F Okada; J Rak
Journal:  Mol Med       Date:  1998-05       Impact factor: 6.354

7.  Clinical outcome in stage I to III breast carcinoma and eIF4E overexpression.

Authors:  B D Li; J C McDonald; R Nassar; A De Benedetti
Journal:  Ann Surg       Date:  1998-05       Impact factor: 12.969

8.  Tissue microarray analysis of eIF4E and its downstream effector proteins in human breast cancer.

Authors:  Heather E Kleiner; Prasad Krishnan; Jesse Tubbs; Mark Smith; Carol Meschonat; Runhua Shi; Mary Lowery-Nordberg; Patrick Adegboyega; Marcia Unger; James Cardelli; Quyen Chu; J Michael Mathis; John Clifford; Arrigo De Benedetti; Benjamin D L Li
Journal:  J Exp Clin Cancer Res       Date:  2009-01-09

9.  Understanding and Targeting the Eukaryotic Translation Initiation Factor eIF4E in Head and Neck Cancer.

Authors:  Biljana Culjkovic; Katherine L Borden
Journal:  J Oncol       Date:  2009-12-13       Impact factor: 4.375

10.  Identification of an exonic splicing silencer in exon 6A of the human VEGF gene.

Authors:  Rui Wang; Ronald G Crystal; Neil R Hackett
Journal:  BMC Mol Biol       Date:  2009-11-17       Impact factor: 2.946

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.